Monday, August 26
Dr. David SHERR
Title: The AHR: A Major Player in Cancer Aggression and Immune Checkpoint Regulation
Dr. Sherr received his B.A. from Brandeis University in 1973 and his PhD from Cornell University in 1978. He was a postdoctoral fellow at Harvard Medical School in the laboratories of Drs. Baruj Benacerraf (Nobel Laureate, 1980) and Martin Dorf from 1978 to 1981, after which he was appointed to the position of Assistant Professor (1982) and then Associate Professor (1987) of Pathology at Harvard Medical School. In 1993 Dr. Sherr was recruited to Boston University as Professor of Environmental Health and Professor of Pathology and Laboratory Medicine and is the Director of the Boston University Superfund Research Program and Director of the Find The Cause Breast Cancer Foundation Research Consortium. Since that time he has studied the role of the AHR in immune cell development and in tumorigenesis, specifically with regard to its role in production and function of immunosuppressive immune cells. He has published 127 peer-reviewed manuscripts. His lab has been continually funded by the NIH since 1986. He has trained 26 postdoctoral and 13 predoctoral fellows and 8 undergraduates, has served on 67 doctoral committees, and has won The Boston University School of Public Health Excellence in Teaching Award 3 times.
